Gäste-Forum » the Ministry of Road Transport

Infectious Disease Therapeutics Market – Variables Sidney Crosby Jersey Authentic , Emerging Trends, Future Growth Strategies, Segments And Forecast By 2025
by nareshpatil · January 3, 2019

San Francisco, 03 Jan 2019 – 聽鈥淚nfectious Disease Therapeutics Market Analysis By Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, and HPV infection), By Region, And Segment Forecasts, 2018 – 2025鈥?– The global聽top 6 infectious disease therapeutics market聽is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.聽

To request a sample copy or view summary of this report, click the link below:
Further Key Findings From the Report Suggest:


The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH Access More Reports Of The Same Category: Grand View Research has segmented the top 6 infectious disease therapeutics market on the basis of disease type and region:
Disease Type Outlook (Revenue, USD Million, 2014 – 2025)


HIV Emtriva Aptivus Isentress LexivaTelzir Selzentry Tivicay Atripla Complera Genvoya Odefsey Stribild Truvada Triumeq Descovy Vitekta Others Influenza Relenza Tamiflu Rapivab Others TB Sirturo Others Malaria Coartem Others HPV Hepatitis Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America US. Canada Europe Germany UK Asia Pacific China Japan Latin America Brazil Mexico Middle East & Africa South Africa Browse Press Release of this Report: About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The聽company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: The National Highways Authority of India (NHAI), launched a new surveillance system under its ongoing Advanced Traffic Management System (ATMS) project to ease the flow of traffic and operations on roads. To this end, the Centre鈥檚 autonomous agency already started deploying the surveillance system in various toll plazas in the country.


The NHAI鈥檚 parent organisation, the Ministry of Road Transport and Highways (MoRTH), opines that the new surveillance system will eliminate traffic congestion on roads especially on highways, which currently facilitate around 40 percent of trade and commerce in the country. The NHAI, under the supervision of the MoRTH, is further set to install the new surveillance system at 10 Toll plazas by 2018.


Over the next six months, the National Highways Authority of India is planning to position IP cameras at 10 major Toll gates to improve security at Toll gates. Later, it may implement the surveillance system in all the major Toll booths in the country. The new surveillance system is built with sophisticated imaging technology and smart IP cameras to collect real-time data on the flow of traffic.


Once the surveillance equipmen. Cheap Jerseys Wholesale Jerseys Cheap Jerseys Cheap Jerseys From China Cheap Nike NFL Jerseys Wholesale NFL Jerseys China Wholesale Jerseys Cheap Nike NFL Jerseys Wholesale NFL Jerseys Free Shipping Cheap NFL Jerseys